FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:1967-1976 May 12, 2005 Number 19 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Supplementary Material Editorial by Shapiro, S. D. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Lin, A. Y. PubMed Citation

ABSTRACT

Background Chronic obstructive pulmonary disease (COPD) is characterized by chronic airway inflammation that is greater in patients with advanced disease. We asked whether there is a link between the severity of disease and the reduction in histone deacetylase (HDAC) activity in the peripheral lung tissue of patients with COPD of varying severity. HDAC is a key molecule in the repression of production of proinflammatory cytokines in alveolar macrophages.

Methods HDAC activity and histone acetyltransferase (HAT) activity were determined in nuclear extracts of specimens of surgically resected lung tissue from nonsmokers without COPD, patients with COPD of varying severity, and patients with pneumonia or cystic fibrosis. Alveolar macrophages from nonsmokers, smokers, and patients with COPD and bronchial-biopsy specimens from nonsmokers, healthy smokers, patients with COPD, and those with mild asthma were also examined. Total RNA extracted from lung tissue and macrophages was used for quantitative reverse-transcriptase–polymerase-chain-reaction assay of HDAC1 through HDAC8 and interleukin-8. Expression of HDAC2 protein was quantified with the use of Western blotting. Histone-4 acetylation at the interleukin-8 promoter was evaluated with the use of a chromatin immunoprecipitation assay.

Results Specimens of lung tissue obtained from patients with increasing clinical stages of COPD had graded reductions in HDAC activity and increases in interleukin-8 messenger RNA (mRNA) and histone-4 acetylation at the interleukin-8 promoter. The mRNA expression of HDAC2, HDAC5, and HDAC8 and expression of the HDAC2 protein were also lower in patients with increasing severity of disease. HDAC activity was decreased in patients with COPD, as compared with normal subjects, in both the macrophages and biopsy specimens, with no changes in HAT activity, whereas HAT activity was increased in biopsy specimens obtained from patients with asthma. Neither HAT activity nor HDAC activity was changed in lung tissue from patients with cystic fibrosis or pneumonia.

Conclusions Patients with COPD have a progressive reduction in total HDAC activity that reflects the severity of the disease.

Source Information

From the Airway Disease Section, National Heart and Lung Institute, Imperial College, London (K.I., M.I., B.C., O.M.K., I.M.A., P.J.B.); the Chest and Allergy Clinic, St. Mary's Hospital, London (O.M.K.); University of British Columbia and the James Hogg iCAPTURE Center for Cardiovascular and Pulmonary Research, St. Paul's Hospital, Vancouver, B.C., Canada (W.M.E., S.H., J.C.H.); the Department of Clinical and Experimental Medicine, Centro di Ricerca su Asma e Broncopneumopatia Cronica Ostruttiva, University of Ferrara, Ferrara, Italy (G.C.); and the Department of Pneumology, Silesian Medical Academy, Katowice, Poland (A.B.).

Address reprint requests to Dr. Barnes at the National Heart and Lung Institute, Imperial College, Dovehouse St., London SW3 6LY, United Kingdom, or at p.j.barnes{at}imperial.ac.uk.

Full Text of this Article

This article has been cited by other articles:

• Suissa, S., Barnes, P. J. (2009). Inhaled corticosteroids in COPD: the case against. Eur Respir J 34: 13-16 [Full Text]  
• Bartling, T. R., Drumm, M. L. (2009). Loss of CFTR results in reduction of histone deacetylase 2 in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 297: L35-L43 [Abstract] [Full Text]  
• Cosio, M. G., Saetta, M., Agusti, A. (2009). Immunologic Aspects of Chronic Obstructive Pulmonary Disease. NEJM 360: 2445-2454 [Full Text]  
• Osoata, G. O., Hanazawa, T., Brindicci, C., Ito, M., Barnes, P. J., Kharitonov, S., Ito, K. (2009). Peroxynitrite Elevation in Exhaled Breath Condensate of COPD and Its Inhibition by Fudosteine. Chest 135: 1513-1520 [Abstract] [Full Text]  
• Cosio, B G, Iglesias, A, Rios, A, Noguera, A, Sala, E, Ito, K, Barnes, P J, Agusti, A (2009). Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD. Thorax 64: 424-429 [Abstract] [Full Text]  
• Gaschler, G. J., Skrtic, M., Zavitz, C. C. J., Lindahl, M., Onnervik, P.-O., Murphy, T. F., Sethi, S., Stampfli, M. R. (2009). Bacteria Challenge in Smoke-exposed Mice Exacerbates Inflammation and Skews the Inflammatory Profile. Am. J. Respir. Crit. Care Med. 179: 666-675 [Abstract] [Full Text]  
• Adenuga, D., Yao, H., March, T. H., Seagrave, J., Rahman, I. (2009). Histone Deacetylase 2 Is Phosphorylated, Ubiquitinated, and Degraded by Cigarette Smoke. Am. J. Respir. Cell Mol. Bio. 40: 464-473 [Abstract] [Full Text]  
• Marwick, J. A., Caramori, G., Stevenson, C. S., Casolari, P., Jazrawi, E., Barnes, P. J., Ito, K., Adcock, I. M., Kirkham, P. A., Papi, A. (2009). Inhibition of PI3K{delta} Restores Glucocorticoid Function in Smoking-induced Airway Inflammation in Mice. Am. J. Respir. Crit. Care Med. 179: 542-548 [Abstract] [Full Text]  
• Suzuki, M., Betsuyaku, T., Ito, Y., Nagai, K., Odajima, N., Moriyama, C., Nasuhara, Y., Nishimura, M. (2009). Curcumin attenuates elastase- and cigarette smoke-induced pulmonary emphysema in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 296: L614-L623 [Abstract] [Full Text]  
• Bhattacharya, S., Srisuma, S., DeMeo, D. L., Shapiro, S. D., Bueno, R., Silverman, E. K., Reilly, J. J., Mariani, T. J. (2009). Molecular Biomarkers for Quantitative and Discrete COPD Phenotypes. Am. J. Respir. Cell Mol. Bio. 40: 359-367 [Abstract] [Full Text]  
• Singh, S., Amin, A. V., Loke, Y. K. (2009). Long-term Use of Inhaled Corticosteroids and the Risk of Pneumonia in Chronic Obstructive Pulmonary Disease: A Meta-analysis. Arch Intern Med 169: 219-229 [Abstract] [Full Text]  
• Yang, S.-R., Yao, H., Rajendrasozhan, S., Chung, S., Edirisinghe, I., Valvo, S., Fromm, G., McCabe, M. J. Jr., Sime, P. J., Phipps, R. P., Li, J.-D., Bulger, M., Rahman, I. (2009). RelB Is Differentially Regulated by I{kappa}B Kinase-{alpha} in B Cells and Mouse Lung by Cigarette Smoke. Am. J. Respir. Cell Mol. Bio. 40: 147-158 [Abstract] [Full Text]  
• Ito, K., Barnes, P. J. (2009). COPD as a Disease of Accelerated Lung Aging. Chest 135: 173-180 [Abstract] [Full Text]  
• Marik, P. E. (2009). Critical Illness-Related Corticosteroid Insufficiency. Chest 135: 181-193 [Abstract] [Full Text]  
• Bartling, T. R., Drumm, M. L. (2009). Oxidative Stress Causes IL8 Promoter Hyperacetylation in Cystic Fibrosis Airway Cell Models. Am. J. Respir. Cell Mol. Bio. 40: 58-65 [Abstract] [Full Text]  
• Rahman, I. (2008). Review: Antioxidant therapeutic advances in COPD. Ther Adv Respir Dis 2: 351-374 [Abstract]  
• Ito, K., Herbert, C., Siegle, J. S., Vuppusetty, C., Hansbro, N., Thomas, P. S., Foster, P. S., Barnes, P. J., Kumar, R. K. (2008). Steroid-Resistant Neutrophilic Inflammation in a Mouse Model of an Acute Exacerbation of Asthma. Am. J. Respir. Cell Mol. Bio. 39: 543-550 [Abstract] [Full Text]  
• Seemungal, T., Sykes, A., and the ICEAD Contributors, (2008). Recent advances in exacerbations of COPD. Thorax 63: 850-852 [Full Text]  
• Meja, K. K., Rajendrasozhan, S., Adenuga, D., Biswas, S. K., Sundar, I. K., Spooner, G., Marwick, J. A., Chakravarty, P., Fletcher, D., Whittaker, P., Megson, I. L., Kirkham, P. A., Rahman, I. (2008). Curcumin Restores Corticosteroid Function in Monocytes Exposed to Oxidants by Maintaining HDAC2. Am. J. Respir. Cell Mol. Bio. 39: 312-323 [Abstract] [Full Text]  
• Adcock, I. M., Barnes, P. J. (2008). Molecular Mechanisms of Corticosteroid Resistance. Chest 134: 394-401 [Abstract] [Full Text]  
• Marumo, T., Hishikawa, K., Yoshikawa, M., Fujita, T. (2008). Epigenetic Regulation of BMP7 in the Regenerative Response to Ischemia. J. Am. Soc. Nephrol. 19: 1311-1320 [Abstract] [Full Text]  
• Chung, K. F., Adcock, I. M. (2008). Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 31: 1334-1356 [Abstract] [Full Text]  
• Yang, S.-R., Valvo, S., Yao, H., Kode, A., Rajendrasozhan, S., Edirisinghe, I., Caito, S., Adenuga, D., Henry, R., Fromm, G., Maggirwar, S., Li, J.-D., Bulger, M., Rahman, I. (2008). IKK{alpha} Causes Chromatin Modification on Pro-Inflammatory Genes by Cigarette Smoke in Mouse Lung. Am. J. Respir. Cell Mol. Bio. 38: 689-698 [Abstract] [Full Text]  
• Yao, H., Edirisinghe, I., Rajendrasozhan, S., Yang, S.-R., Caito, S., Adenuga, D., Rahman, I. (2008). Cigarette smoke-mediated inflammatory and oxidative responses are strain-dependent in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 294: L1174-L1186 [Abstract] [Full Text]  
• Falk, J. A., Minai, O. A., Mosenifar, Z. (2008). Inhaled and Systemic Corticosteroids in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 5: 506-512 [Abstract] [Full Text]  
• Lee, C.-W., Lin, C.-C., Luo, S.-F., Lee, H.-C., Lee, I.-T., Aird, W. C., Hwang, T.-L., Yang, C.-M. (2008). Tumor Necrosis Factor-{alpha} Enhances Neutrophil Adhesiveness: Induction of Vascular Cell Adhesion Molecule-1 via Activation of Akt and CaM Kinase II and Modifications of Histone Acetyltransferase and Histone Deacetylase 4 in Human Tracheal Smooth Muscle Cells. Mol. Pharmacol. 73: 1454-1464 [Abstract] [Full Text]  
• Rajendrasozhan, S., Yang, S.-R., Kinnula, V. L., Rahman, I. (2008). SIRT1, an Antiinflammatory and Antiaging Protein, Is Decreased in Lungs of Patients with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 177: 861-870 [Abstract] [Full Text]  
• Churg, A., Cosio, M., Wright, J. L. (2008). Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am. J. Physiol. Lung Cell. Mol. Physiol. 294: L612-L631 [Abstract] [Full Text]  
• Dahl, J. A., Collas, P. (2008). {micro}ChIP--a rapid micro chromatin immunoprecipitation assay for small cell samples and biopsies. Nucleic Acids Res 36: e15-e15 [Abstract] [Full Text]  
• Renda, T., Baraldo, S., Pelaia, G., Bazzan, E., Turato, G., Papi, A., Maestrelli, P., Maselli, R., Vatrella, A., Fabbri, L. M., Zuin, R., Marsico, S. A., Saetta, M. (2008). Increased activation of p38 MAPK in COPD. Eur Respir J 31: 62-69 [Abstract] [Full Text]  
• Dombrowsky, H., Uhlig, S. (2007). Steroids and histone deacetylase in ventilation-induced gene transcription. Eur Respir J 30: 865-877 [Abstract] [Full Text]  
• Stevenson, C. S., Docx, C., Webster, R., Battram, C., Hynx, D., Giddings, J., Cooper, P. R., Chakravarty, P., Rahman, I., Marwick, J. A., Kirkham, P. A., Charman, C., Richardson, D. L., Nirmala, N. R., Whittaker, P., Butler, K. (2007). Comprehensive gene expression profiling of rat lung reveals distinct acute and chronic responses to cigarette smoke inhalation. Am. J. Physiol. Lung Cell. Mol. Physiol. 293: L1183-L1193 [Abstract] [Full Text]  
• Suissa, S., McGhan, R., Niewoehner, D., Make, B. (2007). Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 4: 535-542 [Abstract] [Full Text]  
• Chang, J., Mosenifar, Z. (2007). Differentiating COPD From Asthma in Clinical Practice. J Intensive Care Med 22: 300-309 [Abstract]  
• Li, L.-b., Leung, D. Y. M., Strand, M. J., Goleva, E. (2007). ATF2 impairs glucocorticoid receptor mediated transactivation in human CD8+ T cells. Blood 110: 1570-1577 [Abstract] [Full Text]  
• James, A. L., Wenzel, S. (2007). Clinical relevance of airway remodelling in airway diseases. Eur Respir J 30: 134-155 [Abstract] [Full Text]  
• Yoshida, T., Tuder, R. M. (2007). Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease. Physiol. Rev. 87: 1047-1082 [Abstract] [Full Text]  
• Celli, B. R., Barnes, P. J. (2007). Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 29: 1224-1238 [Abstract] [Full Text]  
• Ito, K., Caramori, G., Adcock, I. M. (2007). Therapeutic Potential of Phosphatidylinositol 3-Kinase Inhibitors in Inflammatory Respiratory Disease. J. Pharmacol. Exp. Ther. 321: 1-8 [Abstract] [Full Text]  
• Sutherland, E. R. (2007). Inhaled Steroids and Outcomes in COPD: Progressing Beyond FEV1. Chest 131: 648-649 [Full Text]  
• Livingston, E., Chaudhuri, R., McMahon, A. D., Fraser, I., McSharry, C. P., Thomson, N. C. (2007). Systemic sensitivity to corticosteroids in smokers with asthma. Eur Respir J 29: 64-71 [Abstract] [Full Text]  
• Maeda, Y., Dave, V., Whitsett, J. A. (2007). Transcriptional Control of Lung Morphogenesis. Physiol. Rev. 87: 219-244 [Abstract] [Full Text]  
• Yoshikawa, M., Hishikawa, K., Marumo, T., Fujita, T. (2007). Inhibition of Histone Deacetylase Activity Suppresses Epithelial-to-Mesenchymal Transition Induced by TGF-beta1 in Human Renal Epithelial Cells. J. Am. Soc. Nephrol. 18: 58-65 [Abstract] [Full Text]  
• Barnes, P J (2006). Theophylline for COPD. Thorax 61: 742-743 [Full Text]  
• Hirano, T, Yamagata, T, Gohda, M, Yamagata, Y, Ichikawa, T, Yanagisawa, S, Ueshima, K, Akamatsu, K, Nakanishi, M, Matsunaga, K, Minakata, Y, Ichinose, M (2006). Inhibition of reactive nitrogen species production in COPD airways: comparison of inhaled corticosteroid and oral theophylline. Thorax 61: 761-766 [Abstract] [Full Text]  
• Cookson, W. O. C. (2006). State of the Art. Genetics and Genomics of Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 3: 473-475 [Full Text]  
• Tuder, R. M., Yoshida, T., Arap, W., Pasqualini, R., Petrache, I. (2006). State of the Art. Cellular and Molecular Mechanisms of Alveolar Destruction in Emphysema: An Evolutionary Perspective. Proc Am Thorac Soc 3: 503-510 [Abstract] [Full Text]  
• Barnes, P. J. (2006). Against the dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases.. Am. J. Respir. Crit. Care Med. 174: 240-243 [Full Text]  
• Yin, Z., Gonzales, L., Kolla, V., Rath, N., Zhang, Y., Lu, M. M., Kimura, S., Ballard, P. L., Beers, M. F., Epstein, J. A., Morrisey, E. E. (2006). Hop functions downstream of Nkx2.1 and GATA6 to mediate HDAC-dependent negative regulation of pulmonary gene expression. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L191-L199 [Abstract] [Full Text]  
• Barnes, P. J., Chowdhury, B., Kharitonov, S. A., Magnussen, H., Page, C. P., Postma, D., Saetta, M. (2006). Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 174: 6-14 [Abstract] [Full Text]  
• Szulakowski, P., Crowther, A. J. L., Jimenez, L. A., Donaldson, K., Mayer, R., Leonard, T. B., MacNee, W., Drost, E. M. (2006). The Effect of Smoking on the Transcriptional Regulation of Lung Inflammation in Patients with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 174: 41-50 [Abstract] [Full Text]  
• Berenson, C. S., Wrona, C. T., Grove, L. J., Maloney, J., Garlipp, M. A., Wallace, P. K., Stewart, C. C., Sethi, S. (2006). Impaired Alveolar Macrophage Response to Haemophilus Antigens in Chronic Obstructive Lung Disease. Am. J. Respir. Crit. Care Med. 174: 31-40 [Abstract] [Full Text]  
• Yang, S.-R., Chida, A. S., Bauter, M. R., Shafiq, N., Seweryniak, K., Maggirwar, S. B., Kilty, I., Rahman, I. (2006). Cigarette smoke induces proinflammatory cytokine release by activation of NF-{kappa}B and posttranslational modifications of histone deacetylase in macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L46-L57 [Abstract] [Full Text]  
• Rodriguez-Roisin, R (2006). COPD exacerbations {middle dot} 5: Management.. Thorax 61: 535-544 [Abstract] [Full Text]  
• Fabbri, L. M., Luppi, F., Beghe, B., Rabe, K. F. (2006). Update in chronic obstructive pulmonary disease 2005.. Am. J. Respir. Crit. Care Med. 173: 1056-1065 [Full Text]  
• Anderson, G. P. (2006). COPD, asthma and C-reactive protein.. Eur Respir J 27: 874-876 [Full Text]  
• Slevogt, H., Schmeck, B., Jonatat, C., Zahlten, J., Beermann, W., van Laak, V., Opitz, B., Dietel, S., N'Guessan, P. D., Hippenstiel, S., Suttorp, N., Seybold, J. (2006). Moraxella catarrhalis induces inflammatory response of bronchial epithelial cells via MAPK and NF-{kappa}B activation and histone deacetylase activity reduction. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L818-L826 [Abstract] [Full Text]  
• Xu, Y., Sengupta, P. K., Seto, E., Smith, B. D. (2006). Regulatory Factor for X-box Family Proteins Differentially Interact with Histone Deacetylases to Repress Collagen {alpha}2(I) Gene (COL1A2) Expression. J. Biol. Chem. 281: 9260-9270 [Abstract] [Full Text]  
• Schottenfeld, D., Beebe-Dimmer, J. (2006). Chronic inflammation: a common and important factor in the pathogenesis of neoplasia.. CA Cancer J Clin 56: 69-83 [Abstract] [Full Text]  
• KIM, J.-S., SHUKLA, S. D. (2006). ACUTE IN VIVO EFFECT OF ETHANOL (BINGE DRINKING) ON HISTONE H3 MODIFICATIONS IN RAT TISSUES. Alcohol Alcohol 41: 126-132 [Abstract] [Full Text]  
• Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P. J., Adcock, I. M. (2006). Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-{kappa}B suppression. JEM 203: 7-13 [Abstract] [Full Text]  
• Barnes, P. J. (2006). Reduced Histone Deacetylase in COPD: Clinical Implications. Chest 129: 151-155 [Abstract] [Full Text]  
• Chung, K. F. (2005). The Role of Airway Smooth Muscle in the Pathogenesis of Airway Wall Remodeling in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 2: 347-354 [Abstract] [Full Text]  
• Houslay, M. D. (2005). The Long and Short of Vascular Smooth Muscle Phosphodiesterase-4 As a Putative Therapeutic Target. Mol. Pharmacol. 68: 563-567 [Abstract] [Full Text]  
• Lin, A. Y., Bhowmik, A., Barnes, P. J., Adcock, I. M., Ito, K. (2005). Histone Deacetylase Activity and COPD. NEJM 353: 528-529 [Full Text]  
• Nachman, S A (2005). Severity of COPD is linked to decreased histone deacetylase activity. Thorax 60: 594-594 [Full Text]  
• Shapiro, S. D. (2005). COPD Unwound. NEJM 352: 2016-2019 [Full Text]